The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Research works printed but not linked: 13
- Come, 1987, Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator, J Am Coll Cardiol, 10, 971, 10.1016/S0735-1097(87)80333-9 · doi:10.1016/s0735-1097(87)80333-9
- Verstraete, 1988, Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism, Circulation, 77, 353, 10.1161/01.CIR.77.2.353 · DOI · Paper page
- Goldhaber, 1986, Acute pulmonary embolism treated with tissue plasminogen aclivator, Lancet, 2, 886, 10.1016/S0140-6736(86)90411-3 · doi:10.1016/s0140-6736(86)90411-3
- Goldhaber, 1988, A randomized controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism, Lancet, 2, 293, 10.1016/S0140-6736(88)92354-9 · DOI · Paper page
- Levine, 1990, A randomized trial of a single bolus regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism, Chest, 98, 1473, 10.1378/chest.98.6.1473 · DOI · Paper page
- Miller, 1971, Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism, Br Med J, 2, 681, 10.1136/bmj.2.5763.681 · DOI · Paper page
- Palla, 1985, Radiographic assesment of perfusion impairment in pulmonary embolism, Eur J Radiol, 5, 252
- UPET, 1973, The urokinase pulmonary embolism trial (UPET): a national co-operative study, Circulation, 47, II-1
- Meyer, 1992, Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial, J Am Coll Cardiol, 19, 239, 10.1016/0735-1097(92)90472-Y · DOI · Paper page
- Gissi-2, 1990, A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction, Lancet, 336, 65
- 1992, ISIS 3: a randomised comparison of streptokinase vstissue plasminogen activator vsanistreplase and of aspirin plus heparin vsaspirin alone among 41299 cases of suspected acute myocardial infarction, Lancet, 339, 753, 10.1016/0140-6736(92)91893-D · DOI · Paper page
- Gore, 1991, Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the thrombolysis in myocardial infarction study, Circulation, 83, 448, 10.1161/01.CIR.83.2.448 · DOI · Paper page
- Levine, 1990, New short infusion dosage regimen of recombinant tissue plasminogen activator in patients with venous thromboembolic disease, Chest, 97, 168S, 10.1378/chest.97.4_Supplement.168S · DOI
Cited by
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Konstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz405 · Cited by 4,916
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
Self-citationOrtel, T. L., Neumann, I., Ageno, W., Beyth, R., Clark, N. P., Cuker, A., Hutten, B. A., Jaff, M. R., Manja, V., Schulman, S., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001830 · Cited by 1,489
“We identified 29 systematic reviews(151-179) and 26 RCTs (n 5 2787).(130,180-204) Trials included individuals with an objectively confirmed symptomatic PE.”
Background
Metadata
- Authors
- Dalla-Volta, S., Palla, A., Santolicandro, A., Giuntini, C., Pengo, V., Visioli, O., Zonzin, P., Zanuttini, D., Barbaresi, F., Agnelli, G., Morpurgo, M., Marini, M. G., & Visani, L.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 1992-09
- Volume
- 20
- Issue
- 3
- Pages
- 520-526
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2009344499
- Cited by
- 379
- References
- 1
- FWCI
- 5.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 7623 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. https://app.cochat.ai/papers/10.1016/0735-1097(92)90002-5
- The paper
- Dalla-Volta, S., Palla, A., Santolicandro, A., Giuntini, C., Pengo, V., Visioli, O., Zonzin, P., Zanuttini, D., Barbaresi, F., Agnelli, G., Morpurgo, M., Marini, M. G., & Visani, L. (1992). PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. Journal of the American College of Cardiology. https://doi.org/10.1016/0735-1097(92)90002-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
